en
Scientific article
English

Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study

Published inThe Lancet. Haematology, vol. 7, no. 1, p. e50-e60
Publication date2020
Abstract

The success of unrelated haemopoietic cell transplantation (HCT) is limited by graft-versus-host disease (GVHD), which is the main post-transplantation challenge when HLA-matched donors are unavailable. A sequence dimorphism in exon 1 of HLA-B gives rise to leader peptides containing methionine (Met; M) or threonine (Thr; T), which differentially influence natural killer and T-cell alloresponses. The main aim of the study was to evaluate the role of the leader dimorphism in GVHD after HLA-B-mismatched unrelated HCT.

Keywords
  • Adolescent
  • Adult
  • Exons/genetics
  • Female
  • Graft vs Host Disease/genetics/immunology
  • HLA-B Antigens/genetics
  • Hematopoietic Stem Cell Transplantation/methods
  • Histocompatibility
  • Histocompatibility Testing
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Retrospective Studies
Citation (ISO format)
PETERSDORF, Effie W et al. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study. In: The Lancet. Haematology, 2020, vol. 7, n° 1, p. e50–e60. doi: 10.1016/S2352-3026(19)30208-X
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2352-3026
184views
0downloads

Technical informations

Creation02/04/2021 10:45:00 AM
First validation02/04/2021 10:45:00 AM
Update time03/16/2023 12:07:14 AM
Status update03/16/2023 12:07:13 AM
Last indexation01/17/2024 12:31:29 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack